Baoming Qin
qin_baoming@gibh.ac.cn
Chinese, English
Guangdong
University of Chinese Academy of Sciences
Medical School
  • 2007-09--2010-07 PhD: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
  • 1994-09--1998-06 Bachelor's: School of Life Sciences, Peking University
  • 2013-09~2017-08 - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Researcher
  • 2010-07~2013-08 - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Associate Researcher
  • Guangdong Province 'Special Support Plan' for Leading Talents in Scientific and Technological Innovation (2016)
  • Second Prize for Research on Mechanisms of Stem Cell Pluripotency and Reprogramming (2013)
  • Chinese Academy of Sciences Excellent Doctoral Dissertation (2011)
  • Chinese Academy of Sciences President's Award for Excellence (2010)
  • Chinese Academy of Sciences Outstanding Graduate (2010)
Stem Cell Fate Control
Induced Pluripotent Stem Cell Technology
Mitochondrial Reactive Oxygen Species
Epigenetic Barriers in Reprogramming
Autophagy and mTORC1 in Cellular Remodeling
  • Rolling back of human pluripotent stem cells to an 8-cell embryo-like stage, Mazid Md. Abdul, Miguel A. Esteban, 2022
  • Translational and post-translational control of human naïve versus primed pluripotency, Cheng Chen, Xiaobing Zhang, Yisha Wang, Xinyu Chen, Wenjie Chen, Songsong Dan, Shiqi She, Weiwei Hu, Jie Dai, Jianwen Hu, Qingyi Cao, Qianyu Liu, Yinghua Huang, Baoming Qin, Bo Kang, YingJie Wang, 2022
  • Cell transcriptomic atlas of the non-human primate Macaca fascicularis, Not mentioned, 2022
  • Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays, Ao Chen, Sha Liao, Mengnan Cheng, Kailong Ma, Liang Wu, Yiwei Lai, Xiaojie Qiu, Jin Yang, Jiangshan Xu, Shijie Hao, Xin Wang, Huifang Lu, Xi Chen, Xing Liu, Xin Huang, Zhao Li, Yan Hong, Yujia Jiang, Jian Peng, Shuai Liu, Mengzhe Shen, Chuanyu Liu, Quanshui Li, Yue Yuan, Xiaoyu Wei, Huiwen Zheng, Weimin Feng, Zhifeng Wang, Yang Liu, Zhaohui Wang, Yunzhi Yang, Haitao Xiang, Lei Han, Baoming Qin, Pengcheng Guo, Guangyao Lai, Pura MuozCnoves, Patrick H Maxwell, Jean Paul Thiery, QingFeng Wu, Fuxiang Zhao, Bichao Chen, Mei Li, Xi Dai, Shuai Wang, Haoyan Kuang, Junhou Hui, Liqun Wang, JiFeng Fei, Ou Wang, Xiaofeng Wei, Haorong Lu, Bo Wang, Shiping Liu, Ying Gu, Ming Ni, Wenwei Zhang, Feng Mu, Ye Yin, Huanming Yang, Michael Lisby, Richard J Cornall, Jan Mulder, Mathias Uhln, Miguel A Esteban, Yuxiang Li, Longqi Liu, Xun Xu, Jian Wang, 2022
  • The mTORC1-eIF4F axis controls paused pluripotency, Xu, Xueting, Ahmed, Tanveer, Wang, Lulu, Cao, Xintao, Zhang, Zeyu, Wang, Ming, Lv, Yuan, Kanwal, Shahzina, Tariq, Muqddas, Lin, Runxia, Zhang, Hui, Huang, Yinghua, Peng, Hao, Lin, Danni, Shi, Xue, Geng, Didi, Liu, Baohua, Zhang, Xiaofei, Yi, Wen, Qin, Yan, Esteban, Miguel A, Qin, Baoming, 2021
  • beta-Catenin safeguards the ground state of mouse pluripotency by strengthening the robustness of the transcriptional apparatus, Zhang, Meng, Lai, Yiwei, Krupalnik, Vladislav, Guo, Pengcheng, Guo, Xiangpeng, Zhou, Jianguo, Xu, Yan, Yu, Zhijun, Liu, Longqi, Jiang, Ao, Li, Wenjuan, Ma, Gang, Li, Na, Fu, Xiuling, Lv, Yuan, Jiang, Mengling, Tariq, Muqddas, Kanwal, Shahzina, Liu, Hao, Xu, Xueting, Zhang, Hui, Huang, Yinghua, Wang, Lulu, Chen, Shuhan, Babarinde, Isaac A, Luo, Zhiwei, Wang, Dongye, Zhou, Tiantian, Ward, Carl, He, Minghui, Ibanez, David P, Li, Yunpan, Zhou, Jiajian, Yuan, Jie, Feng, Yayan, Arumugam, Karthik, Di Vicino, Umberto, Bao, Xichen, Wu, Guangming, Schambach, Axel, Wang, Huating, Sun, Hao, Gao, Fei, Qin, Baoming, Hutchins, Andrew P, Doble, Bradley W, Hartmann, Christine, Cosma, Maria Pia, Qin, Yan, Xu, GuoLiang, Chen, Runsheng, Volpe, Giacomo, Chen, Liang, Hanna, Jacob H, Esteban, Miguel A, 2020
  • JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency, Yinghua Huang, Hui Zhang, Lulu Wang, Chuanqing Tang, Xiaogan Qin, Xinyu Wu, Meifang Pan, Yujia Tang, Zhongzhou Yang, Isaac A Babarinde, Runxia Lin, Guanyu Ji, Yiwei Lai, Xueting Xu, Jianbin Su, Xue Wen, Takashi Satoh, Tanveer Ahmed, Vikas Malik, Carl Ward, Giacomo Volpe, Lin Guo, Jinlong Chen, Li Sun, Yingying Li, Xiaofen Huang, Xichen Bao, Fei Gao, Baohua Liu, Hui Zheng, Ralf Jauch, Liangxue Lai, Guangjin Pan, Jiekai Chen, Giuseppe Testa, Shizuo Akira, Jifan Hu, Duanqing Pei, Andrew P Hutchins, Miguel A Esteban, Baoming Qin, 2020
  • Exonuclease combinations reduce noises in 3D genomics technologies, Kong, Siyuan, Li, Qing, Zhang, Gaolin, Li, Qiujia, Huang, Qitong, Huang, Lei, Zhang, Hui, Huang, Yinghua, Peng, Yanling, Qin, Baoming, Zhang, Yubo, 2020
  • mTORC1-PGC1 axis regulates mitochondrial remodeling during reprogramming, Wang, Lulu, Xu, Xueting, Jiang, Che, Ma, Gang, Huang, Yinghua, Zhang, Hui, Lai, Yiwei, Wang, Ming, Ahmed, Tanveer, Lin, Runxia, Guo, Wenjing, Luo, Zhiwei, Li, Wenjuan, Zhang, Meng, Ward, Carl, Qian, Minxian, Liu, Baohua, Esteban, Miguel A, Qin, Baoming, 2020
  • RNA结合蛋白在多能干细胞命运转变中的研究进展, 王秀芹, 尹梦然, 夏晴, 王丽莎, 秦宝明, 姚红杰, 2020
  • Role of Long Non-coding RNAs in Reprogramming to Induced Pluripotency, Kanwal, Shahzina, Guo, Xiangpeng, Ward, Carl, Volpe, Giacomo, Qin, Baoming, Esteban, Miguel A, Bao, Xichen, 2020
  • PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson-Gilford progeria syndrome, Wang, Ming, Wang, Lulu, Qian, Minxian, Tang, Xiaolong, Liu, Zuojun, Lai, Yiwei, Ao, Ying, Huang, Yinghua, Meng, Yuan, Shi, Lei, Peng, Linyuan, Cao, Xinyue, Wang, Zimei, Qin, Baoming, Liu, Baohua, 2020
  • Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9, Chen, Shuhan, Luo, Zhiwei, Ward, Carl, Ibanez, David P, Liu, Hao, Zhong, Xiaofen, Sharma, Narendra K, Qin, Baoming, Fan, Wenxia, Wang, Dongye, 2020
  • Nuclear-cytoplasmic shuttling of class IIa histone deacetylases regulates somatic cell reprogramming, Zhiwei Luo, Xiaobing Qing, Christina Benda, Zhijian Huang, Meng Zhang, Yinghua Huang, Hui Zhang, Lulu Wang, Yiwei Lai, Carl Ward, Giacomo Volpe, Xiaofen Zhong, Baoming Qin, Qiang Zhuang, Miguel A Esteban, Wenjuan Li, 2019
  • Generation of Rybp homozygous knockout murine ES cell line GIBHe001-A-1 by using CRISPR/Cas9 technology, Liu, Zicong, Yao, Mingze, Yao, Hongjie, Hu, Gongcheng, Qin, Baoming, 2019
  • Profiling the long noncoding RNA interaction network in the regulatory elements of target genes by chromatin in situ reverse transcription sequencing, Zhang, Shilin, Wang, Yichen, Jia, Lin, Wen, Xue, Du, Zhonghua, Wang, Cong, Hao, Yajing, Yu, Dehai, Zhou, Lei, Chen, Naifei, Chen, Jingchen, Chen, Huiling, Zhang, Hui, Celik, Ilkay, Gulsoy, Gunhan, Luo, Jianjun, Qin, Baoming, Cui, Xueling, Liu, Zhonghui, Zhang, Songling, Esteban, Miguel A, Ay, Ferhat, Xu, Wei, Chen, Runsheng, Li, Wei, Hoffman, Andrew R, Hu, Jifan, Cui, Jiuwei, 2019
  • Generation of an induced pluripotent stem cell line (GIBHi003-A) from a Parkinson's disease patient with mutant PINK1 (p. I368N), Abdul, Mazid Md, Ibanez, David P, Zhao, Ping, Liu, Hao, Zhong, Xiaofen, Li, Yingying, Zhang, Meng, Li, Wenjuan, Li, Yunpan, Ward, Carl, Chen, Shuhan, Wang, Dongye, Qin, Baoming, Esteban, Miguel A, Wang, Xiwei, Fan, Wenxia, Luo, Zhiwei, 2019
  • Profiling the long noncoding RNA interaction network in the regulatory elements 2 of target genes by chromatin in situ reverse transcription sequencing, 秦宝明, 2019
  • Generation of a PARK2 homozygous knockout induced pluripotent stem cell line (GIBHi002-A-1) with two common isoforms abolished, Zhang, Meng, Ibaneza, David P, Fan, Wenxia, Liu, Hao, Zhong, Xiaofen, Wang, Xiwei, Li, Yingying, Abdul, Mazid Md, Li, Wenjuan, Li, Yunpan, Ward, Carl, Chen, Shuhan, Wang, Dongye, Qin, Baoming, Esteban, Miguel A, Zhao, Ping, Luo, Zhiwei, 2019
  • A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Stem Cell Fate Control Pluripotent Reprogramming Mitochondria Reactive Oxygen Species Epigenetics Autophagy Mtorc1 Longevity

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.